Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms

Oncotarget

Volumn 7, Issue 43, 2016, Pages 69579-69591

  Freeman, Joshua R ^a,b   Chu, Su ^a   Hsu, Thomas ^c   Huang, Yen Tsung ^a,d  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c BROWN UNIVERSITY   (United States)

^d INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

Author keywords

DNA methylation; Epigenetics; Non small cell lung cancer; Smoking

Indexed keywords

AGED; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE LOCUS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; SMOKING; SQUAMOUS CELL LUNG CARCINOMA; GENETIC PREDISPOSITION; GENETICS; LEAST SQUARE ANALYSIS; LUNG TUMOR; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PROCEDURES; STATISTICAL MODEL;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CPG ISLANDS; DNA METHYLATION; EPIGENOMICS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING;

EID: 84994235621     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11831     Document Type: Article

References (63)

1. Leone AA. Toxics of tobacco smoke and cardiovascular system: From functional to cellular damage. Curr Pharm Des. 2015.
2. Khan RJ, Stewart CP, Davis SK, Harvey DJ, Leistikow BN. The risk and burden of smoking related heart disease mortality among young people in the United States. Tob Induc Dis. 2015; 13:16.
3. Vancheri CC. IPF, comorbidities and management implications. Sarcoidosis Vasc Diffuse Lung Dis. 32:17.
4. Huang R, Wei Y, Hung RJ, Liu G, Su L, Zhang R, Zong X, Zhang ZF, Morgenstern H, Bruske I, Heinrich J, Hong YC, Kim JH, et al. Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine. 2015; 2:1677-1685.
5. Wang Y, Duan H, Yang X, Guo J. Cigarette smoking and the risk of pancreatic cancer: a case-control study. Med Oncol. 2014; 31:184.
6. Liu M, Zhou C, Zheng J. Cigarette smoking impairs the response of EGFR-TKIs therapy in lung adenocarcinoma patients by promoting EGFR signaling and epithelial-mesenchymal transition. Am J Transl Res. 2015; 7:2026-2035.
7. World Health Organization. Tobacco. (http://www.who.int/mediacentre/factsheets/fs339/en/: WHO). 2015.
8. Organization WH. Prevalence of tobacco use. Global Health Observation (GHO) Data. (http://www.who.int/gho/tobacco/use/en/: WHO). 2016.
9. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005; 116:963-971.
10. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011; 32:605-644.
11. Breast cancer survival rates, by stage. Breast Cancer 2016 5/4/2016 [cited 2016; Available from: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-survival-by-stage
12. Prostate cancer stages. Prostate Cancer 3/11/2016 [cited; Available from: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-survival-rates
13. Miller OJ, Schnedl W, Allen J, Erlanger BF. 5-Methylcytosine localised in mammalian constitutive heterochromatin. Nature. 1974; 251:636-637.
14. Hou L, Zhang X, Wang D, Baccarelli A. Environmental chemical exposures and human epigenetics. Int J Epidemiol. 2012; 41:79-105.
15. Vaissiere T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, Ferro G, Paliwal A, Hainaut P, Brennan P, Tost J, Boffetta P, Herceg Z. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res. 2009; 69:243-252.
16. Vineis P, Perera F. Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007; 16:1954-1965.
17. Villalba M, Diaz-Lagares A, Redrado M, de Aberasturi AL, Segura V, Bodegas ME, Pajares MJ, Pio R, Freire J, Gomez-Roman J, Montuenga LM, Esteller M, Sandoval J, et al. Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients. Oncotarget. 2016; 7:22752-22769. doi: 10.18632/oncotarget.8045.
18. Fasanelli F, Baglietto L, Ponzi E, Guida F, Campanella G, Johansson M, Grankvist K, Johansson M, Assumma MB, Naccarati A, Chadeau-Hyam M, Ala U, Faltus C, et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat Commun. 2015; 6:10192.
19. Koh YW, Chun SM, Park YS, Song JS, Lee GK, Khang SK, Jang SJ. Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma. Tumour Biol. 2016.
20. Leduc N, Ahomadegbe C, Agossou M, Aline-Fardin A, Mahjoubi L, Dufrenot-Petitjean Roget L, Grossat N, Vinh-Hung V, Lamy A, Sabourin JC, Molinie V. Incidence of Lung Adenocarcinoma Biomarker in a Caribbean and African Caribbean Population. J Thorac Oncol. 2016; 11:769-773.
21. Jin Y, Xu P, Liu X, Zhang C, Tan C, Chen C, Sun X, Xu Y. Cigarette Smoking, BPDE-DNA Adducts, and Aberrant Promoter Methylations of Tumor Suppressor Genes (TSGs) in NSCLC from Chinese Population. Cancer Invest. 2016; 34:173-180.
22. Zeilinger SS. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PloS One. 2013; 8:e63812.
23. Sun YV. Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. Human Genet. 2013; 132:1027.
24. Huang YT, Lin X, Liu Y, Chirieac LR, McGovern R, Wain J, Heist R, Skaug V, Zienolddiny S, Haugen A, Su L, Fox EA, Wong KK, et al. Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer. Proc Natl Acad Sci USA. 2011; 108:16345-16350.
25. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002; 3:461-469.
26. Hecht SS, Stepanov I, Carmella SG. Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines. Acc Chem Res. 2016; 49:106-114.
27. Ligthart S, Steenaard RV, Peters MJ, van Meurs JB, Sijbrands EJ, Uitterlinden AG, Bonder MJ, consortium B, Hofman A, Franco OH, Dehghan A. Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes. Diabetologia. 2016.
28. Dogan MV, Lei MK, Beach SR, Brody GH, Philibert RA. Alcohol and tobacco consumption alter hypothalamic pituitary adrenal axis DNA methylation. Psychoneuroendocrinology. 2016; 66:176-184.
29. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2002; 62:2370-2377.
30. Ambatipudi S, Cuenin C, Hernandez-Vargas H, Ghantous A, Calvez-Kelm FL, Kaaks R, Barrdahl M, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Naska A, Palli D, et al. Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study. Epigenomics. 2016.
31. Zhu X, Li J, Deng S, Yu K, Liu X, Deng Q, Sun H, Zhang X, He M, Guo H, Chen W, Yuan J, Zhang B, et al. Genome-Wide Analysis of DNA Methylation and Cigarette Smoking in Chinese. Environ Health Persp. 2016.
32. Cortessis VK. Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Human Genet. 2012; 131:1565.
33. Feil RR. Epigenetics and the environment: emerging patterns and implications. Nature Rev Genet. 2011; 13:97.
34. Shenker NS, Polidoro S, van Veldhoven K, Sacerdote C, Ricceri F, Birrell MA, Belvisi MG, Brown R, Vineis P, Flanagan JM. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet. 2013; 22:843-851.
35. Zaghlool SB. Association of DNA methylation with age, gender, and smoking in an Arab population. Clin Epigenetics. 2015; 7:6.
36. Besingi W, Johansson A. Smoke-related DNA methylation changes in the etiology of human disease. Hum Mol Gen. 2014; 23:2290-2297.
37. Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013; 13:246-257.
38. Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 2014; 15:642-656.
39. Hong W, Guan KL. The YAP, TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol. 2012; 23:785-793.
40. Lau AN, Curtis SJ, Fillmore CM, Rowbotham SP, Mohseni M, Wagner DE, Beede AM, Montoro DT, Sinkevicius KW, Walton ZE, Barrios J, Weiss DJ, Camargo FD, et al. Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. EMBO J. 2014; 33:468-481.
41. Xie M, Zhang L, He CS, Hou JH, Lin SX, Hu ZH, Xu F, Zhao HY. Prognostic significance of TAZ expression in resected non-small cell lung cancer. J Thorac Oncol. 2012; 7:799-807.
42. Noguchi S, Saito A, Horie M, Mikami Y, Suzuki HI, Morishita Y, Ohshima M, Abiko Y, Mattsson JS, Konig H, Lohr M, Edlund K, Botling J, et al. An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer. Clin Cancer Res. 2014; 20:4660-4672.
43. Abdel-Fatah TM, Albarakati N, Bowell L, Agarwal D, Moseley P, Hawkes C, Ball G, Chan S, Ellis IO, Madhusudan S. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy. Breast Cancer Res Treat. 2013; 142:515-527.
44. Sweasy JB, Lang T, DiMaio D. Is base excision repair a tumor suppressor mechanism? Cell cycle. 2006; 5:250-259.
45. Deslee G, Adair-Kirk TL, Betsuyaku T, Woods JC, Moore CH, Gierada DS, Conradi SH, Atkinson JJ, Toennies HM, Battaile JT, Kobayashi DK, Patterson GA, Holtzman MJ, et al. Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts. Am J Respir Cell Mol Biol. 2010; 43:576-584.
46. Mao YY. MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC). Biomed Pharmacother. 2015; 76:82.
47. Nebl G, Cato AC. NFI/X proteins: a class of NFI family of transcription factors with positive and negative regulatory domains. Cell Mol Biol Res. 1995; 41:85-95.
48. Ordway JM, Budiman MA, Korshunova Y, Maloney RK, Bedell JA, Citek RW, Bacher B, Peterson S, Rohlfing T, Hall J, Brown R, Lakey N, Doerge RW, et al. Identification of novel high-frequency DNA methylation changes in breast cancer. PloS One. 2007; 2:e1314.
49. Ray BK, Dhar S, Henry C, Rich A, Ray A. Epigenetic regulation by Z-DNA silencer function controls cancer-associated ADAM-12 expression in breast cancer: cross-talk between MeCP2 and NF1 transcription factor family. Cancer Res. 2013; 73:736-744.
50. Hosgood HD, 3rd, Menashe I, Shen M, Yeager M, Yuenger J, Rajaraman P, He X, Chatterjee N, Caporaso NE, Zhu Y, Chanock SJ, Zheng T, et al. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis. 2008; 29:1938-1943.
51. Saito H, Fujiwara T, Shin S, Okui K, Nakamura Y. Cloning and mapping of a human novel cDNA (NHP2L1) that encodes a protein highly homologous to yeast nuclear protein NHP2. Cytogenet Cell Genet. 1996; 72:191-193.
52. Schultz A, Nottrott S, Watkins NJ, Luhrmann R. Protein-protein and protein-RNA contacts both contribute to the 15.5K-mediated assembly of the U4/U6 snRNP and the box C/D snoRNPs. Mol Cell Biol. 2006; 26:5146-5154.
53. Falvella FS, Frullanti E, Galvan A, Spinola M, Noci S, De Cecco L, Nosotti M, Santambrogio L, Incarbone M, Alloisio M, Calabro E, Pastorino U, Skaug V, et al. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. Int J Cancer. 2009; 124:2880-2885.
54. Hicks C, Miele L, Koganti T, Young-Gaylor L, Rogers D, Vijayakumar V, Megason G. Analysis of Patterns of Gene Expression Variation within and between Ethnic Populations in Pediatric B-ALL. Cancer Inform. 2013; 12:155-173.
55. Pasmant E, Masliah-Planchon J, Levy P, Laurendeau I, Ortonne N, Parfait B, Valeyrie-Allanore L, Leroy K, Wolkenstein P, Vidaud M, Vidaud D, Bieche I. Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients. Mol Med. 2011; 17:79-87.
56. Hata T, Ogawa T, Yokoyama TA, Fukushige S, Horii A, Furukawa T. DSCP1, a novel TP53-inducible gene, is upregulated by strong genotoxic stresses and its overexpression inhibits tumor cell growth in vitro. Int J Oncol. 2004; 24:513-520.
57. van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, Zeegers MP. Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis. J Urol. 2016; 195:872-879.
58. TeschendorffAE, Yang Z, Wong A, Pipinikas CP, Jiao Y, Jones A, Anjum S, Hardy R, Salvesen HB, Thirlwell C, Janes SM, Kuh D, Widschwendter M. Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer. JAMA Oncol. 2015; 1:476-485.
59. Houseman EA, Molitor J, Marsit CJ. Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics. 2014; 30:1431-1439.
60. International Cancer Genome C, Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabe RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, et al. International network of cancer genome projects. Nature. 2010; 464:993-998.
61. Leek JT JW, Parker HS, Fertig EJ, Jaffe AE, Storey JD. sva: Surrogate Variable Analysis. R package version 3. 2015; 19.0.
62. Strimmer K. fdrtool: a versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics. 2008; 24:1461-1462.
63. White IR, Thompson SG. Adjusting for partially missing baseline measurements in randomized trials. Stat Med. 2005; 24:993-1007.